Fitzbio Research HubEducational content only — not medical advice

Growth-hormone research

CJC-1295 without DAC

A GHRH analogue used in laboratory endocrine-signalling research.

10 connected records10 graded citations0 external identifiers

Research context

A GHRH analogue used in laboratory endocrine-signalling research.

Regulatory note: Verify local laws, product approval and professional guidance before any human use. This profile is not a recommendation for use.

Evidence map

Claims linked to original records.

Evidence levels describe study design. They do not by themselves establish safety or effectiveness.

Not yet classified

Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

pubmed 2026
Not yet classified

Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M · Frontiers in endocrinology

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

pmc 2026
Not yet classified

&NA; · Springer Science and Business Media LLC

CJC 1131* [DAC: GLP-1] is effective in reducing glucose levels in patients with type 2 diabetes mellitus,

crossref 2004
Not yet classified

Emma Le Nezet, Chloé Marqueze-Pouey, Katy Vaillancourt, Vanessa Couture, Nancy Côté, Marie-Annick Clavel · Elsevier BV

Fibrosis Without Macrocalcification: A Novel In Vitro Model to Study Aortic Valve Disease

crossref 2026
Not yet classified

Seyed Mahdi Sedighi, Tamas Fulop, Adel Mohammadpour, Michel Nguyen, Patrick Prud’Homme, Abdelouahed Khalil · Elsevier BV

Elevated Cardiac Troponin Levels in Geriatric Patients Without ACS: Role of Comorbidities

crossref 2021
Not yet classified

Nicolas Dostie, Arman Sarshoghi, Alexis Doucet, Robert Avram, Jean-François Tanguay, Guillaume Marquis-Gravel · Elsevier BV

Adjustment of Antiplatelet Therapy in Patients With Myocardial Infarction Treated Without Revascularization: A Retrospective Cohort Study

crossref 2025
Not yet classified

Bianca Lê, Mar Janna Dahl, Kurt H. Albertine, Megan R. Sutherland, Mary Jane Black · Elsevier BV

Preterm Birth With Neonatal Interventions Accelerates Collagen Deposition in the Left Ventricle of Lambs Without Affecting Cardiomyocyte Development

crossref 2021
Not yet classified

X. Wu, M. Ghosh M, P. Raggi, H. Becher, J. Windram, D. Vine · Elsevier BV

Progression of Atherosclerosis and Left Ventricular Dysfunction in High-Risk Young Women With and Without Polycystic Ovary Syndrome

crossref 2025
Not yet classified

Rosalind Groenewoud, Sorush Rokui, Byron H. Gottschalk, Defen Peng, Nicholas Sinclair, Jian Ye · Elsevier BV

Long-Term Outcomes After Mitral Valve Replacement in Sex- and Age-Matched Patients With vs Without Mitral Annular Calcification

crossref 2025
Not yet classified

Frédérique Dubé, Etienne Croteau, Gabriel Richard, Catherine Allard, Warner M. Mampuya · Elsevier BV

Exercise Capacity and Perceived Exertion on Treadmill Stress Test Performed While Wearing vs Without a Surgical Mask: A Randomized Clinical Trial in Healthy Adults

crossref 2022

Connected data hub

Records with source provenance.

Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.

Open Access Article

1 records
pmcAutomated import

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M · Frontiers in endocrinology

PMC133228922026-09-27

Publication

1 records
pubmedAutomated import

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M

423951762026-09-27

Scholarly Work

8 records
crossrefAutomated import

Fibrosis Without Macrocalcification: A Novel In Vitro Model to Study Aortic Valve Disease

Emma Le Nezet, Chloé Marqueze-Pouey, Katy Vaillancourt, Vanessa Couture, Nancy Côté, Marie-Annick Clavel · Elsevier BV

10.1016/j.cjco.2026.07.0062026-07-01
crossrefAutomated import

Adjustment of Antiplatelet Therapy in Patients With Myocardial Infarction Treated Without Revascularization: A Retrospective Cohort Study

Nicolas Dostie, Arman Sarshoghi, Alexis Doucet, Robert Avram, Jean-François Tanguay, Guillaume Marquis-Gravel · Elsevier BV

10.1016/j.cjco.2025.04.0122025-07-01
crossrefAutomated import

Progression of Atherosclerosis and Left Ventricular Dysfunction in High-Risk Young Women With and Without Polycystic Ovary Syndrome

X. Wu, M. Ghosh M, P. Raggi, H. Becher, J. Windram, D. Vine · Elsevier BV

10.1016/j.cjco.2025.04.0502025-06-01
crossrefAutomated import

Long-Term Outcomes After Mitral Valve Replacement in Sex- and Age-Matched Patients With vs Without Mitral Annular Calcification

Rosalind Groenewoud, Sorush Rokui, Byron H. Gottschalk, Defen Peng, Nicholas Sinclair, Jian Ye · Elsevier BV

10.1016/j.cjco.2025.02.0112025-05-01
crossrefAutomated import

Exercise Capacity and Perceived Exertion on Treadmill Stress Test Performed While Wearing vs Without a Surgical Mask: A Randomized Clinical Trial in Healthy Adults

Frédérique Dubé, Etienne Croteau, Gabriel Richard, Catherine Allard, Warner M. Mampuya · Elsevier BV

10.1016/j.cjco.2022.07.0092022-12-01
crossrefAutomated import

Preterm Birth With Neonatal Interventions Accelerates Collagen Deposition in the Left Ventricle of Lambs Without Affecting Cardiomyocyte Development

Bianca Lê, Mar Janna Dahl, Kurt H. Albertine, Megan R. Sutherland, Mary Jane Black · Elsevier BV

10.1016/j.cjco.2020.12.0172021-05-01
crossrefAutomated import

Elevated Cardiac Troponin Levels in Geriatric Patients Without ACS: Role of Comorbidities

Seyed Mahdi Sedighi, Tamas Fulop, Adel Mohammadpour, Michel Nguyen, Patrick Prud’Homme, Abdelouahed Khalil · Elsevier BV

10.1016/j.cjco.2020.07.0172021-03-01
crossrefAutomated import

CJC 1131* [DAC: GLP-1] is effective in reducing glucose levels in patients with type 2 diabetes mellitus,

&NA; · Springer Science and Business Media LLC

10.2165/00128413-200414340-000272004-04-01

Live discovery

Latest research signals

Live results from PubMed, ClinicalTrials.gov and UniProt. These may not yet have been reviewed or stored in the Data Hub.

Responsible use of information

Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.